NCT05228132 - The Pristine Post-Market Study | Biotech Hunter

Enrollment

142

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

September 21, 2022

Study Completion Date

September 21, 2022

Conditions

Kidney Failure, ChronicHemodialysis ComplicationHemodialysis Catheter InfectionHemodialysis Access FailureCentral Venous Catheter Related Bloodstream InfectionEnd Stage Renal Disease

Interventions

DEVICE

Pristine™ Long-Term Hemodialysis Catheter

Placement of the Pristine™ Long-Term Hemodialysis Catheter Placement.

Trial Locations (6)

27610

North Carolina Nephrology, PA, Raleigh

36301

Trinity Research Group LLC, Dothan

48202

Henry Ford Health System, Detroit

71103

Louisiana State University Health Shreveport Medical Center, Shreveport

06520

Yale University, New Haven

02906

JML Research Associates, Providence